Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: Curr Protoc Pharmacol. 2015 Dec 8;71:1.34.1–1.3421. doi: 10.1002/0471141755.ph0134s71

Table 7.

Sample transformation of competition binding against [3H]-(+)-PTZ

Final unlabeled inhibitor concentration (M) Specific [3H]-(+)-PTZ Bound (DPM) % Specific Binding
1.00E-05 851 5.25
3.00E-06 950 6.06
1.00E-06 1250 8.51
3.00E-07 3521 27.10
1.00E-07 5420 42.64
3.00E-08 8210 65.47
1.00E-08 10886 87.37
3.00E-09 11253 90.37
1.00E-09 12011 96.57
3.00E-10 12296 98.91

The first column displays the concentrations of unlabeled inhibitor as determined by serial dilution (Table 6). The second column shows mean of quadruplicate counts (in DPM) measured. Values in the third column are derived using Equation 3 where the nonspecific binding value was 209 DPM and the total binding was 12220 DPM.